← Back to Screener
Oculis Holding AG Warrants (OCSAW)
Price$6.50
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)53.22%
Price vs S&P 500 (4W)-36.06%
VGM Score65.82
All Metrics
Price vs S&P 500 (YTD)33.71%
10-Day Avg Trading Volume0.00M
3-Month Avg Trading Volume0.00M
52-Week High$22.64
26-Week Price Return69.15%
13-Week Price Return43.46%
3-Month Return Std Dev141.00%
Year-to-Date Return43.46%
5-Day Price Return-25.17%
Month-to-Date Return-23.77%
Price vs S&P 500 (13W)33.71%
Beta1.22x
52-Week Low$4.85
mGradeB
vgmGradeB
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OCSAWOculis Holding AG Warrants | — | — | B | $6.50 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Oculis Holding AG is a biopharmaceutical company developing targeted therapies for eye diseases and vision disorders. Its pipeline includes OCS-01 for diabetic macular edema, OCS-02 for dry eye disease, and OCS-05 for acute optic neuritis and other neuro-ophthalmologic conditions including glaucoma and diabetic retinopathy. The company employs topical and disease-modifying approaches to address significant unmet needs in ophthalmology.